Journal article

Study Rationale and Design of ADVANCE: Action in and vascular disease - preterax and diamicron MR evaluation

J Chalmers, M Cooper, E Ferrannini, P Glasziou, D Grobbee, P Hamet, S Harrap, L Liu, S MacMahon, G Mancia, M Marre, D Matthews, C Mogensen, B Neal, CY Pan, N Poulter, A Rodgers, B Williams, M Woodward

Diabetologia | SPRINGER-VERLAG | Published : 2001


AIMS/HYPOTHESIS: Patients with Type II (non-insulin-dependent) diabetes mellitus are at increased risk of macrovascular and microvascular disease, both of which are reduced by controlling raised blood pressure in hypertensive patients. Intensive glycaemic control has also been shown to reduce microvascular disease but the effects on macrovascular disease remain uncertain. This study will examine the hypotheses that lowering blood pressure with an ACE inhibitor-diuretic combination and intensively controlling gylcaemia with a sulphonylurea-based regimen in high-risk patients with Type II diabetes (both hypertensive and non-hypertensive) reduces the incidence of macrovascular and microvascular..

View full abstract

University of Melbourne Researchers